Estimates Revisions Genmab A/S Deutsche Boerse AG
Stocks
GE9
DK0010272202
Biotechnology & Medical Research
|
Real-time Estimate
Tradegate
05:29:09 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 307.15 EUR | -2.09% |
|
-1.04% | +13.48% |
| 09-29 | Nordic stocks in North America - Ericsson rose 1.7 percent | FW |
| 09-24 | AbbVie Says Health Canada Issues Notice of Compliance for EPKINLY in Follicular Lymphoma | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Genmab A/S(GMAB)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Genmab A/S(GMAB)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Genmab A/S(GMAB)
EBIT
Dividend / Share (DPS)
Data source:
Genmab A/S(GMAB)
Cash or Net Debt
- Stock Market
- Stocks
- GMAB Stock
- GE9 Stock
- Consensus Genmab A/S
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
